Home1541 • HKG
add
ImmuneOnco Biopharmaceuticls Shanghi Inc
Previous close
$7.33
Day range
$7.20 - $7.91
Year range
$3.21 - $31.40
Market cap
2.73B HKD
Avg Volume
13.71M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 359.50K | -36.03% |
Operating expense | 74.60M | -11.89% |
Net income | -82.88M | 2.97% |
Net profit margin | -23.05K | -51.69% |
Earnings per share | — | — |
EBITDA | -71.35M | 11.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 513.04M | -4.87% |
Total assets | 743.27M | 1.70% |
Total liabilities | 143.03M | 77.02% |
Total equity | 600.24M | — |
Shares outstanding | 374.16M | — |
Price to book | 4.58 | — |
Return on assets | -24.97% | — |
Return on capital | -26.59% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -82.88M | 2.97% |
Cash from operations | -61.51M | 7.06% |
Cash from investing | 20.13M | 204.85% |
Cash from financing | 10.75M | -16.08% |
Net change in cash | -30.07M | 56.81% |
Free cash flow | -35.64M | -32.04% |
About
Founded
2015
Website
Employees
150
